COMMUNIQUÉS West-GlobeNewswire

Silexion Therapeutics Announces Completion of Innovative Expanded Development Plan for SIL204 which will be unveiled at the 2025 NeauxCancer Conference
21/03/2025
Silexion Therapeutics to Present Innovative New Expanded Development Plan for SIL204 at the Industry Leading 2025 NeauxCancer Conference, Following Recently Reported Groundbreaking Preclinical data from Orthotopic [...]
FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting
21/03/2025
HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of [...]
BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025
21/03/2025
SUNNYVALE, Calif., March 21, 2025 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced [...]
TOMI Environmental Solutions Expands into Aquaculture with New Partner, Algafeed
21/03/2025
FREDERICK, Md., March 21, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, is pleased to announce the [...]
OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category
21/03/2025
OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category Oxford, UK – 21 March 2025: OXB (LSE: OXB) (the "Company"), a quality and innovation-led cell and gene therapy CDMO, today [...]
Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update
21/03/2025
Conference scheduled for Friday, March 21, 2025 at 10:00 a.m. Eastern time Woburn, Mass., March 21, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company") , a biopharmaceutical company specializing in [...]
Vireo Growth Inc. Files Definitive Information Circular and Provides Merger Transaction Updates
21/03/2025
– Filing of Definitive Information Circular and receipt of shareholder approval mark key milestones in closing process – – Missouri, Nevada and Utah transactions on track to close during the second quarter of 2025 – [...]
23andMe Launches New Homocysteine (MTHFR-Related) Genetic Report and Accompanying Lab Test
21/03/2025
Provides 23andMe+ Premium members with highly requested insight into their likelihood of developing slightly elevated homocysteine levels SAN FRANCISCO, March 21, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME [...]
Anteris Reports One-Year Patient Outcomes for DurAVR® THV
21/03/2025
New class, biomimetic TAVR demonstrates sustained hemodynamic performance to one-year MINNEAPOLIS and BRISBANE, Australia, March 21, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ( Anteris ® or the Company [...]
Pharmaceutical industry delivers value proposition to Finnish Government: billions to be invested by 2030
21/03/2025
ORION CORPORATION PRESS RELEASE 21 MARCH 2025 at 13:00 EET Pharmaceutical industry delivers value proposition to Finnish Government: billions to be invested by 2030 In 2023, pharmaceutical companies invested more than [...]
Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting
21/03/2025
BOSTON and SAN DIEGO, March 21, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]
Conavi Medical Corp. Announces Upsize to its Previously Announced Public Offering
21/03/2025
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 21, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“ Conavi ” or the “ Company ”), a [...]
Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR
21/03/2025
Poster underscores Tivoxavir Marboxil’s potential for the treatment of bird flu, supported by 100% survival in a rodent challenge model, potent suppression of resistant viruses and Phase 1 data Full dataset to be [...]
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
21/03/2025
MELBOURNE, Australia and INDIANAPOLIS, March 21, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug [...]
MedRisk’s 2025 Industry Trends Report Highlights Geographic Disparities and Cost-Saving Strategies in Physical Therapy for Workers’ Compensation
21/03/2025
KING OF PRUSSIA, Pa., March 21, 2025 (GLOBE NEWSWIRE) -- MedRisk, a leading provider of solutions for the casualty claims industry, has released its 2025 Industry Trends Report , focusing on the critical role of early [...]
HUTCHMED Announces NMPA Conditional Approval for TAZVERIK® (tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma
21/03/2025
— First and only EZH2 inhibitor approved by the NMPA — — HUTCHMED’s fourth product, and its first approval in hematological malignancies — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 21, 2025 (GLOBE NEWSWIRE [...]
SANUWAVE Announces Record Quarterly Revenues: Q4 FY2024 Financial Results
21/03/2025
Q4 2024 revenues were $10.3 million , up 47% from Q4 2023. This was an all-time quarterly record for the Company. Full year 2024 revenues were $32.6 million, up 60% from full year 2023 revenues. This was an all-time [...]
Chimerix Reports Fourth Quarter and Year End 2024 Financial Results
21/03/2025
New Drug Application (NDA) for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma Under Review with Prescription Drug User Fee Act (PDUFA) Action Date of August 18, 2025 Acquisition of Chimerix by [...]
Yaqrit secures NIHR grant for pivotal trials of its liver support device, DIALIVE, for patients with liver failure
21/03/2025
Trial to assess intensive care liver support system across 13 UK centers, led by UCL, Royal Free, Kings College and Queen Elizabeth Birmingham Rapid co-primary endpoints measured over 10 and 28 days; readout Q1 2027 [...]

Pages